搜尋結果
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases. Read More. We’re focused on discovering, developing and producing innovative medicines so people with serious diseases can lead better lives.
Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry .
福泰製藥公司 （Vertex Pharmaceuticals, Inc.）是一家總部位於美國 波士頓 的製藥公司。 歷史. [編輯] 1989年由 約書亞·博格 [2] 和 凱文·J·金塞拉 創立 [3]。 該公司主要研究和生產各類治療絕症的 小分子藥物，著名產品包括治療囊性纖維化的 伊伐卡托 以及抗C肝藥 特拉匹韋。 2019年9月3日福泰製藥斥資9.5億美元收購生物技術公司Semma Therapeutics。 參考文獻. [編輯] ^ Vertex Pharmaceuticals Incorporated. Hoover's. [24 June 2012]. （原始內容 存檔 於2012-09-07）. ^ Weisman, Robert.
2 天前 · Vertex Pharmaceuticals Incorporated Investors: InvestorInfo@vrtx.com Susie Lisa, CFA: +1 617-341-6108 or Miroslava Minkova: +1 617-341-6135 Media: mediainfo@vrtx.com or International: +44 20 3204 ...
5 天前 · Vertex Pharmaceuticals Incorporated(VRTX)，Yahoo奇摩股市提供您即時報價、個股走勢、成交資訊、當日籌碼，價量變化、個股相關新聞等即時資訊。
2 天前 · -- Phase 3 abstract selected for presentation in “Best Abstract” session --BOSTON--(BUSINESS WIRE)--Oct. 18, 2024-- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor for the treatment of moderate-to-severe acute pain, at the annual ...
2024年7月22日 · Find the latest Vertex Pharmaceuticals Incorporated (VRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.
Vertex Pharmaceuticals strikes at the core of serious diseases to change people's lives – learn about our mission, values and recognition.
福泰制药公司 （Vertex Pharmaceuticals, Inc.）是一家总部位于美国 波士顿 的制药公司。 历史. [编辑] 1989年由 约书亚·博格 [2] 和 凯文·J·金塞拉 创立 [3]。 该公司主要研究和生产各类治疗绝症的 小分子药物，著名产品包括治疗囊性纤维化的 伊伐卡托 以及抗丙肝药 特拉匹韦。 2019年9月3日福泰制药斥资9.5亿美元收购生物技术公司Semma Therapeutics。 参考文献. [编辑] ^ Vertex Pharmaceuticals Incorporated. Hoover's. [24 June 2012]. （原始内容 存档 于2012-09-07）. ^ Weisman, Robert.
2024年8月22日 · Vertex Announces Positive Results From Pivotal Trials of Vanzacaftor/Tezacaftor/Deutivacaftor, Next-In-Class Triple Combination Treatment for Cystic Fibrosis. – Treatment with the once-daily vanza triple CFTR modulator regimen met all primary and key secondary endpoints in two randomized controlled trials in people with CF ages 12 ...
